Oxford Nanopore Technologies

Oxford Nanopore Technologies

Oxford Nanopore makes a novel generation of DNA/RNA sequencing technology that provides rich data, is fast, accessible and easy to use. Our goal is to disrupt the way that biological analyses are currently performed, and open up new applications that have a profound, positive impact on society.

Content by Oxford Nanopore Technologies

3D image of cancer cells growing and spreading on human tissue surface.
A drop of blue liquid being added to a petri dish with a background of a DNA sequencing gel and pink test tubes
A 3D illustration of an adeno-associated virus particle with a detailed, spiky outer structure, floating in a colorful, blurred microscopic environment
A futuristic digital illustration of a glowing DNA double helix surrounded by a network of hexagonal and circular data elements, symbolizing advanced biotechnology and genomic data analysis.
Digital illustration of a double helix surrounded by virus-like particles
A digital illustration of a circular, multicolored genomic data visualization, resembling a DNA sequencing map with concentric patterns of rectangular color blocks on a dark background
Available on Demand
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Close-up of a researcher using a stylus to draw or interact with digital molecular structures on a blue scientific interface.
When molecules outgrow the limits of sketches and strings, researchers need a new way to describe and communicate them.
Portrait of Scott Weitze, Vice President of Research and Technical Standards at My Green Lab, beside text that reads “Tell us what you know: Bringing sustainability into scientific research,” with the My Green Lab logo.
Laboratories account for a surprising share of global emissions and plastic waste, making sustainability a priority for modern research.
3D illustration of RNA molecules on a gradient blue background.
With diverse emerging modalities and innovative delivery strategies, RNA therapeutics are tackling complex diseases and unmet medical needs.
Drug Discovery News September 2025 Issue
Latest IssueVolume 21 • Issue 3 • September 2025

September 2025

September 2025 Issue

Explore this issue